Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Organon & Co. (OGN : NYSE)

• Company Description    Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. Number of Employees: 4,000

• Price / Volume Information    Yesterday's Closing Price: $9.60 Daily Weekly Monthly 20 Day Moving Average: 3,728,139 shares Shares Outstanding: 259.97 (millions) Market Capitalization: $2,495.67 (millions) Beta: 0.63 52 Week High: $19.05 52 Week Low: $8.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.69% -8.24% 12 Week 1.59% -3.74% Year To Date -35.66% -43.13%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 30 Hudson Street FL 33 - Jersey City,NJ 07302 USA ph: 551-430-6900 fax: - investor_relations@organon.com http://www.organon.com

• General Corporate Information    Officers Kevin Ali - Chief Executive Officer Carrie Cox - Chairman of the Board of Directors Matthew Walsh - Chief Financial Officer Kathryn DiMarco - SVP Finance - Corporate Controller Robert Essner - Director Peer Information Organon & Co. (CHCR) Organon & Co. (ESRX) Organon & Co. (MYDP) Organon & Co. (COR) Organon & Co. (GBCS) Organon & Co. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 68622V106 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 10/30/25 Share - Related Items Shares Outstanding: 259.97 Most Recent Split Date: (:1) Beta: 0.63 Market Capitalization: $2,495.67 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.83% Current Fiscal Quarter EPS Consensus Estimate: $0.94 Indicated Annual Dividend: $0.08 Current Fiscal Year EPS Consensus Estimate: $3.68 Payout Ratio: 0.02 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: -0.21 Estmated Long-Term EPS Growth Rate: 3.01% Last Dividend Paid: 08/15/2025 - $0.02 Next EPS Report Date: 10/30/25

• Fundamental Ratios P/E Current FY Estimate: 2.61 Trailing 12 Months: 2.72 PEG Ratio: 0.87 Price Ratios Price/Book: 3.40 Price/Cash Flow: 1.95 Price / Sales: 0.40 EPS Growth vs. Year Ago Period: -8.74% vs. Previous Quarter: -1.05% Sales Growth vs. Year Ago Period: -0.81% vs. Previous Quarter: 5.35% ROE 09/30/25 - - 06/30/25 - 163.88 03/31/25 - 227.43 ROA 09/30/25 - - 06/30/25 - 6.99 03/31/25 - 7.34 Current Ratio 09/30/25 - - 06/30/25 - 1.65 03/31/25 - 1.67 Quick Ratio 09/30/25 - - 06/30/25 - 1.13 03/31/25 - 1.15 Operating Margin 09/30/25 - - 06/30/25 - 14.61 03/31/25 - 14.91 Net Margin 09/30/25 - - 06/30/25 - 11.15 03/31/25 - 11.92 Pre-Tax Margin 09/30/25 - - 06/30/25 - 10.60 03/31/25 - 10.68 Book Value 09/30/25 - - 06/30/25 - 2.82 03/31/25 - 2.09 Inventory Turnover 09/30/25 - - 06/30/25 - 1.99 03/31/25 - 2.01 Debt-to-Equity 09/30/25 - - 06/30/25 - 11.98 03/31/25 - 16.49 Debt-to-Capital 09/30/25 - - 06/30/25 - 92.30 03/31/25 - 94.28

Powered by Zacks Investment Research ©